Suppr超能文献

幽门螺杆菌相关性免疫性血小板减少症:诊断与治疗方法。

Helicobacter pylori-Associated Immune Thrombocytopenia: Diagnostic and Therapeutic Approach.

机构信息

Department of Internal Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka.

Healseq Precision Medicine Private Limited, Indian Institute of Science, Bengaluru, Karnataka.

出版信息

Ann Afr Med. 2024 Jul 1;23(3):248-254. doi: 10.4103/aam.aam_170_23. Epub 2024 Mar 11.

Abstract

The relationship between immune thrombocytopenia (ITP) and Helicobacterpylori infection has largely been an unexplored entity. This review article aims at focusing on the role of H. pylori in secondary ITP. We also elucidated the importance of diagnostic workup and treatment of H. pylori in this article. The mechanisms of H. pylori-associated ITP have been covered in this article. The factors determining platelet response to H. pylori eradication therapy have been mentioned. It is extremely crucial to be aware that H. pylori is a major causative pathogen for new-onset ITP as well as chronic ITP. Upper gastrointestinal endoscopic biopsy is the best invasive method for the diagnosis of the same. Further studies need to be conducted across larger, more diverse groups to validate our observation that eradication of H. pylori could aid platelet recovery in ITP.

摘要

免疫性血小板减少症(ITP)与幽门螺杆菌(H. pylori)感染之间的关系在很大程度上仍是一个未被探索的领域。本文旨在关注 H. pylori 在继发性 ITP 中的作用。我们还阐述了在本文中对 H. pylori 的诊断和治疗的重要性。本文涵盖了与 H. pylori 相关的 ITP 的发病机制。提到了决定血小板对 H. pylori 根除治疗反应的因素。需要注意的是,H. pylori 是新发 ITP 和慢性 ITP 的主要致病病原体。上消化道内镜活检是诊断这种疾病的最佳侵袭性方法。需要进行更多更大、更多样化的研究,以验证我们的观察结果,即根除 H. pylori 可以帮助 ITP 患者的血小板恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd6/11364310/ca5af8ef8d78/AAM-23-248-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验